Life sciences testing services continue to drive strategic growth, as Eurofins Scientific announced a major acquisition in North America. The company has entered into an agreement to acquire the Life Sciences Testing Services business of Element Materials Technology. The acquisition will have an enterprise value of $400 million. Also, the acquisition is subject to certain regulatory approvals and conditions precedent. It is scheduled to be completed in Q4 2026.
Testing Services of Elements’ Life Sciences in North America has several capabilities such as biopharma product testing, environmental testing, & food testing. The business has 27 laboratories and facilities, and it employs about 750 employees. It is expected to earn revenues of more than $150 million annually in 2026. The profitability of the business conforms to average performance in Eurofins Group.
Eurofins Strengthens North American Life Sciences Testing Presence
It will give Eurofins a stronger foothold within North America through increased reach in these under-served markets. These include significant regions in the U.S. and Canada. In addition, Eurofins hopes to increase its life science testing services presence. Lastly, the business will get the advantage of Eurofins’ existing systems. It runs a lab structure called hub-and-spoke laboratories. It makes their operations more efficient and scalable. Consequently, this allows them to offer more services to their customers.
Comment from Dr Gilles Martin, Eurofins CEO: “We look forward to welcoming Element’s North American Life Sciences Testing Services teams into Eurofins. This acquisition is a natural fit with Eurofins’ existing businesses, and can build on our well invested, efficient and digital laboratories platform to help drive unique levels of service to customers across the continent.”
Moreover, the acquisition is in line with Eurofins’ investment plan. The company is concentrating on the development of its testing abilities. Bio-analytical and life sciences testing are preferred by the firm. Therefore, the acquisition will help in ensuring sustained growth in these areas of high demand. On the whole, Eurofins manages to improve its market position through this strategic acquisition. The company expands both in terms of geography and services offered.
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
